07 Apr 2021 | 02:30 PM GMT

Pharma and CROs partnerships with Innovative Clinical Trials Solutions

Participants:

Willie Muehlhausen Co-FounderSafira Clinical Research Limited
Willie Muehlhausen
Co-FounderSafira Clinical Research Limited
Kevin Darcy Director, Link StrategyVeeva
Kevin Darcy
Director, Link StrategyVeeva
AS
Alistair Stuart Innovation LeadAstute Digital Health
AS
Alistair Stuart
Innovation LeadAstute Digital Health
AS
Alistair Stuart Innovation LeadAstute Digital Health
AS
Alistair Stuart
Innovation LeadAstute Digital Health
Erik van der Zijden CEO and FounderSynappz
Erik van der Zijden
CEO and FounderSynappz
JM
john mattison CMIOACP
JM
john mattison
CMIOACP
Joseph Dustin Vice President & General Manager for eCOAMedable, Inc
Joseph Dustin
Vice President & General Manager for eCOAMedable, Inc
Neal Stine VP / General ManageruMed
Neal Stine
VP / General ManageruMed
Olivier Zitoun Global Life Sciences LeaderCapgemini
Olivier Zitoun
Global Life Sciences LeaderCapgemini
Piotr Sokolowski Chief Medtech StrategistS3 Connected Health
Piotr Sokolowski
Chief Medtech StrategistS3 Connected Health
Rasmus Hogreffe VP, Decentralized Clinical Trials InnovationMedable Inc
Rasmus Hogreffe
VP, Decentralized Clinical Trials InnovationMedable Inc
Richard Korman Assoc. Director, Clinical Trial BusinessBristol Myers Squibb
Richard Korman
Assoc. Director, Clinical Trial BusinessBristol Myers Squibb
Todd Greenwood Sr. Director Evidence Generation and OutcomesZS Associates
Todd Greenwood
Sr. Director Evidence Generation and OutcomesZS Associates
Todd Greenwood Director Evidence GenerationZS Associates
Todd Greenwood
Director Evidence GenerationZS Associates

About this Meeting

Many pharma companies and CROs are partnering with digital health companies as a way to improve patient enrollment, collect patient data remotely and optimize the design of the trial. What should pharma and CROs look for when partnering with innovative clinical trials solutions, companies specialized in specific stages (i.e patient recruitment, data collection & analysis, site selection, etc) or end to end products? Where is the greatest, and quickest opportunity to show impact? As benefits for pharma and CROs are probably longer term, how important is it to focus on culture and change in mindset  to make these partnerships thrive? Join this meeting to discuss this and more with thought leaders in the field.